Remarkably, the PI4KA expression-high group genes were mainly enriched in both acute myelocytic leukemia and chronic myelocytic leukemia pathogenesis pathways (Figure 1G-H). The gene discussed is PI4KA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.